(October 8, 2021)
Officials with the FDA have issued an emergency use authorization for PerkinElmer’s PKamp Respiratory SARS-CoV-2 RT-PCR Panel 1 assay, a single test that can detect and differentiate between SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV).
(06.04.2020)
Imagine that you are not carrying the virus, but you go in for testing and leave carrying the virus.
The Telegraph report stated that it is “not clear” how the tests were contaminated.
(30.04.2020)
One of the suppliers – the Luxembourg-based firm Eurofins – sent an email on Monday morning to government laboratories in the UK warning that a delivery of key components called “probes and primers” had been contaminated with coronavirus and would be delayed.
The firm admitted there had been “an issue” and insisted other private providers had suffered the same problem.
(01.03.2020)
A senior administration official added that the government also moved the manufacturing of the coronavirus tests out of the Atlanta laboratory of CDC.
The official said that the CDC engaged with a third party contractor on Feb. 20 to help manufacture the testing kits. The official added that the FDA regulator, Stenzel, visited the Atlanta laboratory on Feb. 22.
(Aug 14, 2015 / no specific date)
(15.12.2021)
In January 2020, the C.D.C. developed a polymerase chain reaction, or P.C.R., test for the virus. (…)
Problems emerged soon after the C.D.C. had begun shipping its test kits out to public health laboratories in early February. (…)
In mid-February, the agency acknowledged that the kits were flawed, and in April, officials at the U.S. Food and Drug Administration said that poor manufacturing practices had resulted in contamination of the test kits.
The new paper presents the results of the C.D.C.’s own internal investigation into the problems with the tests.
(…)
The investigation also confirmed that the test kits had been contaminated with synthetic fragments of the virus’s genetic material.
(16.12.2021)
«After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives»
(July 25, 2021)
The CDC quietly announced last week that it was withdrawing its request to the FDA for Emergency Use Authorization (EUA) of the 2019-Novel Coronavirus PCR Diagnostic Panel for detection of SARS-CoV-2 (the name for the COVID-19 virus). It now recommends laboratories adopt a method that can detect and differentiate SARS-CoV-2 from influenza viruses. The US has used the PCR test to report more than 34.4-million cases of the COVID-19 since the pandemic began and more than 610,000 deaths.
Die angemeldete Teilnehmerzahl des sogenannten „Montagsspaziergangs“ war schnell überschritten, gegen 18.30 Uhr füllte sich der Domplatz mit Demonstrierenden. Die Polizei war mit einem Großaufgebot vor Ort und schätzte rund 1300 Teilnehmer. Bis zum Abend verlief die Demonstration ruhig und ohne Zwischenfälle. In Münster waren schon in der vergangenen Woche rund 1.200 Demonstrierende durch Münsters Innenstadt gezogen.
In Thüringen haben am Sonntag rund 2.900 Menschen gegen die Maßnahmen zur Eindämmung der Corona-Pandemie demonstriert. Die Polizei sprach von insgesamt 17 Demonstrationen in mehreren Städten.
Nachdem bereits in der Vorwoche so viele Menschen wie nie zuvor gegen die Corona-Einschränkungen protestiert hatten, sind auch in der Seenplatte wieder einige tausend Menschen zu den sogenannten Spaziergängen zusammengekommen. Allein in Neubrandenburg zählte die Polizei mehr als 2.000 Teilnehmer. 750 waren es in Waren, knapp 500 bei einer unangemeldeten Demonstration in Neustrelitz und weitere in Malchow und Röbel.